First manufactured nanopharmaceutical drug has been unveiled by Cuba. The drug is a tweaked variety of cyclosporine, used to help prevent transplant rejection.
"Its main advantages are that it can achieve the same favorable effect with a dose three times less powerful, using the most prescribed drug of its kind in its class, and while significantly reducing side effects," lead researcher Dario Lopez told the Communist Party newspaper Granma.
His research included design of the drug, also used to treat arthritis, "in a totally water soluble form, in which cyclosporine appears dissolved in the form of nanoparticles in microcapsules."
Cuba has a biotech research industry focused largely on vaccines, which earns the Americas' only Communist-run country about $400 million a year.